Skip to Main content Skip to Navigation

Régulation de l'expression membranaire du transporteur de phospholipides biliaires ABCB4 : effet de mutations

Abstract : ABCB4 is exclusively expressed at the canalicular membrane of hepatocytes where its function is to translocate phosphatidylcholine (PC) into bile. Variations in ABCB4 gene sequence are associated with several chronic and progressive liver diseases. The most severe is PFIC3 which develops early in childhood and most often requires liver transplantation. Less severe diseases are the intrahepatic cholestasis of pregnancy and the low phospholipid- associated cholelithiasis syndrome which occur in young adults. Up to now, about 500 disease-causing ABCB4 variants have been reported. A challenge is to find pharmacological treatments for the severe forms of the diseases. We have studied the effect of five disease-causing variations that reside in the highly conserved motifs of ABC transporters, involved in ATP binding. Using three-dimension structural modeling and in vitro studies, we showed that the five mutants were normally processed and targeted to the plasma membrane, whereas their PC secretion activity was dramatically decreased. PC secretion activity of the mutants was rescued by the clinically approved CFTR potentiator ivacaftor (VX-770). These results pave the way for personalized therapy in ABCB4-related diseases.The second part of my project was aimed at investigating the potential role of two ABCB4 partners, the kinase MRCKalpha and its effector the myosin light chain II (MLCII) in the expression and function of ABCB4. We found that downregulation of both partners didn’t affect the canalicular localization of ABCB4 but led to a reduction of its endocytosis. Our results open new insights into the mechanisms underlying the regulation of ABCB4 expression and function.
Document type :
Complete list of metadatas

Cited literature [514 references]  Display  Hide  Download
Contributor : Abes Star :  Contact
Submitted on : Thursday, September 10, 2020 - 5:05:41 PM
Last modification on : Friday, October 23, 2020 - 4:41:20 PM


Version validated by the jury (STAR)


  • HAL Id : tel-02935849, version 1


Alix Bruneau. Régulation de l'expression membranaire du transporteur de phospholipides biliaires ABCB4 : effet de mutations. Médecine humaine et pathologie. Sorbonne Université, 2019. Français. ⟨NNT : 2019SORUS048⟩. ⟨tel-02935849⟩



Record views


Files downloads